MaxCyte
MXCT
NASDAQ
IPO2019
about MXCT
MaxCyte is a leader in cellular therapy technologies, offering products and services to enable the development and manufacturing of cell-based therapies for treating various diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $0.74 | $0.78 | $0.73 | $80.27M | 935.40K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.12 | n/a | 11.59 | -207.19% | -181.81% | 0% |